Chemical formula: C₁₉H₂₄N₂O₂ Molecular mass: 312.406 g/mol PubChem compound: 4891
Praziquantel induces a rapid contraction of schistosomes by a specific effect on the permeability of the cell membrane. The medicine further causes vacuolisation and disintegration of the schistosome tegument.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| P02BA01 | Praziquantel | P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02B Antitrematodals → P02BA Quinoline derivatives and related substances |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| BERMOXEL Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC |
Praziquantel is an active ingredient of these brands:
United States (US)Australia (AU)Brazil (BR)Canada (CA)Cyprus (CY)Estonia (EE)France (FR)Hong Kong (HK)Japan (JP)Malta (MT)Mexico (MX)Netherlands (NL)New Zealand (NZ)Nigeria (NG)Singapore (SG)South Africa (ZA)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
